Biomedicines, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
In chemotherapy-induced organ toxicity mitigation
Eman T.
Mehanna
Scholar“Research focused on Chemotherapy-induced organ toxicity mitigation and adjacent fields.”
21
H-index
1.1k
Citations
Eman has not officially claimed their profile. If you are Eman, claim it free.
Claim Your Profile
Pioneer
LOCKED

Pathfinder
LOCKED

Scholar
EARNED

Innovator
LOCKED

Inventor
LOCKED

Catalyst
LOCKED

Expert
UPGRADE
What I study
man T. Mehanna is a researcher working on Chemotherapy-induced organ toxicity mitigation. A fuller summary will appear once they update their profile.
Publication output and reach
Eman's work has been cited 1,083 times across 5 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
Topics
Recent publications
17 worksInternational Journal of Molecular Sciences, Neuroinflammation and Neurodegeneration Mechanisms
ACS Omega, Chemotherapy-induced organ toxicity mitigation
Naunyn-Schmiedeberg s Archives of Pharmacology, Cancer-related Molecular Pathways
Life Sciences, Diabetes Treatment and Management
RSC Medicinal Chemistry, Protein Tyrosine Phosphatases
Biomedicine & Pharmacotherapy, Ziziphus Jujuba Studies and Applications
Archives of Dermatological Research, Immunodeficiency and Autoimmune Disorders
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Eman?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Free to claim · takes a minute to verify it’s you